[Neuropathologic, immunologic and psychobiological aspects of Alzheimer's dementia].

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Fortschritte der Neurologie Psychiatrie

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 8365703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Senile dementia of the Alzheimer type in the lundby study

  2005cited by this paper
• Ultrastructural studies of amyloid fibrils and senile plaques in human brain

  2004cited by this paper
• Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses

  2004cited by this paper
• Immunohistological study of senile brains by using a monoclonal antibody recognizing β amyloid precursor protein: significance of granular deposits in relation with senile plaques

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining

  2004cited by this paper
• Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy

  2004cited by this paper
• Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease

  2004cited by this paper
• Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia

  2004cited by this paper
• Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques

  2004cited by this paper
• Comparison of four staining methods on the detection of neuritic plaques

  2004cited by this paper
• Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease

  2004cited by this paper
• A special type of senile plaque, possibly an initial stage

  2004cited by this paper
• Ultrastructure of the neuropil threads in the Alzheimer brain: their dendritic origin and accumulation in the senile plaques

  2004cited by this paper
• Expression of monoamine oxidase B activity in astrocytes of senile plaques

  2004cited by this paper
• [Chronic bismuth poisoning with encephalopathy and dementia].

  1993cited by this paper
• Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain.

  1992cited by this paper
• Personality changes in Alzheimer's disease.

  1992cited by this paper
• Astroglia in Alzheimer's disease.

  1992cited by this paper
• Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure.

  1992cited by this paper
• The role of amyloid beta-protein in Alzheimer's disease.

  1992cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• Glutamate and other CSF amino acids in Alzheimer's disease.

  1992cited by this paper
• Alzheimer's disease: identical phenotype of familial and non-familial cases

  1992cited by this paper
• beta-Amyloid neurotoxicity: a discussion of in vitro findings.

  1992cited by this paper
• Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.

  1992cited by this paper
• Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

  1992cited by this paper
• Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Regional synaptic pathology in Alzheimer's disease.

  1992cited by this paper
• Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

  1992cited by this paper
• Solvent effects on beta protein toxicity in vivo.

  1992cited by this paper
• Synaptic plasticity: on the trail of the retrograde messenger.

  1992cited by this paper
• Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

  1992cited by this paper
• Tacrine in Alzheimer's disease

  1992cited by this paper
• A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

  1992cited by this paper
• Beta-amyloid precursor protein cleavage by a membrane-bound protease.

  1992cited by this paper
• Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.

  1992cited by this paper
• Effect of beta amyloid peptides on neurons in hippocampal slice cultures.

  1992cited by this paper
• The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

  1992cited by this paper
• The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain.

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells.

  1992cited by this paper
• Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses.

  1992cited by this paper
• [Mental health and social situation in old age].

  1992cited by this paper
• Inhibition of trypsin by the beta-amyloid protein precursor. A comparative study between transfected cells, human brain and cerebrospinal fluid.

  1992cited by this paper
• Individual differences in the cognitive and neurobiological consequences of normal aging.

  1992cited by this paper
• The Alzheimer‐like phosphorylation of tau protein reduces microtubule binding and involves Ser‐Pro and Thr‐Pro motifs

  1992cited by this paper
• Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study

  1992cited by this paper
• Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus.

  1991cited by this paper
• IL-6-mediated events in Alzheimer's disease pathology.

  1991cited by this paper
• Tangle-bearing neurons show more extensive dendritic trees than tangle-free neurons in area CA1 of the hippocampus in Alzheimer's disease.

  1991cited by this paper
• Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study.

  1991cited by this paper
• Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques.

  1991cited by this paper
• Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it".

  1991cited by this paper
• Amyloid precursor protein gene mutation in early-onset Alzheimer's disease.

  1991cited by this paper
• Evidence for axonal loss in regions occupied by senile plaques in Alzheimer cortex.

  1991cited by this paper
• Interleukin-6 in clinical medicine

  1991cited by this paper
• In‐vitro matured human macrophages express Alzheimer's βA4‐amyloid precursor protein indicating synthesis in microglial cells

  1991cited by this paper
• L-deprenyl therapy improves verbal memory in amnesic Alzheimer patients.

  1991cited by this paper
• Effects of a MAO-B inhibitor in the treatment of Alzheimer disease.

  1991cited by this paper
• Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

  1991cited by this paper
• High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan.

  1991cited by this paper
• Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat.

  1991cited by this paper
• Clinical risk factors for Alzheimer's disease

  1991cited by this paper
• Alzheimer patients: preamyloid deposits are immunoreactive with antibodies to extracellular domains of the amyloid precursor protein.

  1991cited by this paper
• Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.

  1991cited by this paper
• High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.

  1991cited by this paper
• Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

  1991cited by this paper
• Very mild Alzheimer's disease

  1991cited by this paper
• SIDAM – A Structured Interview for the diagnosis of Dementia of the Alzheimer type, Multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R

  1991cited by this paper
• Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

  1991cited by this paper
• A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation.

  1991cited by this paper
• Advances in Alzheimer's disease

  1991cited by this paper
• Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.

  1991cited by this paper
• Usual vs. successful aging: some notes on experiential factors.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau.

  1991cited by this paper
• Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.

  1991cited by this paper
• Alternative splicing of the beta A4 amyloid gene of Alzheimer's disease in cortex of control and Alzheimer's disease patients.

  1991cited by this paper
• [Differential diagnosis of dementia diseases. A prospective clinical study with neuropathologic diagnostic verification].

  1991cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Molecular genetics of Alzheimer disease amyloid.

  1991cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper
• BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

  1991cited by this paper
• [Manifestations of Alzheimer's disease in daily living].

  1991cited by this paper
• Absence of aluminium in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies.

  1991cited by this paper
• Glutamate‐, glutaminase‐, and taurine‐immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease

  1991cited by this paper
• Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

  1991cited by this paper
• Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.

  1991cited by this paper
• Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease.

  1991cited by this paper
• Neuritic pathology and dementia in alzheimer's disease

  1991cited by this paper
• Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons.

  1990cited by this paper
• Therapeutic strategies in Alzheimer's disease

  1990cited by this paper
• Neural differentiation increases expression of Alzheimer amyloid protein precursor gene in murine embryonal carcinoma cells.

  1990cited by this paper
• Glycosylation of the amyloid peptide precursor containing the Kunitz protease inhibitor domain improves the inhibition of trypsin.

  1990cited by this paper
• Protease-specificity of Kunitz inhibitor domain of Alzheimer's disease amyloid protein precursor.

  1990cited by this paper
• Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy.

  1990cited by this paper
• Effect of exposure of miners to aluminium powder.

  1990cited by this paper
• Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein.

  1990cited by this paper

• Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity.

  2003cites this paper
• [Significance of personality markers in Alzheimer dementia].

  2000cites this paper
• Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

  1999cites this paper
• Free radicals in Alzheimer's disease.

  1998cites this paper
• A contentious issue in dementia research

  1998cites this paper
• Blood‐Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major Depression: Indication for Disease Subsets

  1997cites this paper
• [Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies].

  1997cites this paper
• [Risk factors in Alzheimer's dementia].

  1996cites this paper
• Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease.

  1996cites this paper
• Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation.

  1995cites this paper
• Interleukin-6 and selected plasma proteins in healthy persons of different ages.

  1994cites this paper
• [Clinical diagnosis and therapeutic possibilities for dementia of the Alzheimer type].

  1994cites this paper